[The pharmacology of drugs used for the treatment of cardiovascular disorders].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D002301:Cardiac Glycosides / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002319:Cardiovascular System / Q000187:drug effects; D006801:Humans; D013565:Sympatholytics / Q000627:therapeutic use*; D013566:Sympathomimetics / Q000009:adverse effects / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002301:Cardiac Glycosides; D013565:Sympatholytics; D013566:Sympathomimetics; D014665:Vasodilator Agents
Pharmakologie der zur Behandlung kardiozirkulatorischer Erkrankungen eingesetzten Mittel